Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating SFRT plus tislelizumab and platinum-based chemotherapy for unresectable stage III non-small cell lung …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating near-infrared fluorescence guided robotic pulmonary segmentectomy for early-stage non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial evaluating Local Ablative Therapy for people with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC [NA]
A clinical trial comparing totally robotic versus surgeon-assisted robotic lung resection for early-stage non-small cell lung cancer; the st…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Synapse 3D With Intravascular Indocyanine Green [Phase 1, Phase 2]
This update notes a Phase 1/2 trial of Synapse 3D with intravascular indocyanine green that is currently recruiting for non-small cell lung …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating tiragolumab in combination with atezolizumab versus placebo with atezolizumab in previously untreated PD-L1-selecte…
-
EMA approval · 2026-01-30EMA Authorised: Pemetrexed Accord (pemetrexed disodium hemipentahydrate) — Accord Healthcare S.L.U.
EMA authorised Pemetrexed Accord (pemetrexed disodium hemipentahydrate) for treatment of non-small cell lung cancer and mesothelioma; market…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: [177Lu]Lu-AKIR001 First-in-human Study [EARLY_Phase 1]
First-in-human early-phase trial of a Lu-177 radiopharmaceutical, [177Lu]Lu-AKIR001, currently recruiting for various advanced cancers.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Emulation of the FLAURA (NCT02296125) Trial Using Specialty Oncology Electronic Health Records Databases
This document reports an observational emulation of the FLAURA trial for first-line treatment in non-small cell lung cancer using specialty …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial update comparing zimberelimab plus domvanalimab with chemotherapy versus pembrolizumab with chemotherapy in patients with untr…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade [Phase 2]
A Phase 2 clinical trial is evaluating a triple combination of docetaxel, ramucirumab, and pembrolizumab for metastatic or recurrent non-sma…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Clinical Study of SHR-A1811 Combined With Pertuzumab as Second-Line Therapy in Patients With HER2-Altered Advanced NSCLC [NA]
Clinical trials.gov reports an update on a study evaluating SHR-A1811 in combination with pertuzumab as second-line therapy for HER2-altered…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer [NA]
This clinical trial update notes that recruitment is ongoing for a study testing adaptive radiation planning to reduce radiation-induced tox…
-
CLINICAL_TRIALS other · 2026-01-30Clinical Trial Update: A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer [Phase 2]
This clinical trial update reports a Phase 2 study comparing Uliledlimab plus Sintilimab and chemotherapy versus Sintilimab plus chemotherap…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
An AstraZeneca-sponsored clinical trial update for a quality improvement study aimed at improving lung cancer care in small and middle-tier …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: IMPT Dose Escalation for NSCLC (HyDose) [NA]
Clinical trial update for HyDose, a dose-escalation study of IMPT in non-small cell lung cancer. It is currently recruiting at University Me…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer [Phase 2, Phase 3]
Clinical trial update for a study comparing Uliledlimab plus Toripalimab, Toripalimab monotherapy, and Pembrolizumab monotherapy in previous…
-
EMA approval · 2026-01-29EMA Authorised: Zykadia (ceritinib) — Novartis Europharm Limited
The European Medicines Agency authorised Zykadia (ceritinib) for the treatment of non-small cell lung cancer. The marketing authorization ho…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 study comparing sotorasib with durvalumab in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study of pembrolizumab (MK-3475) in combination with gemcitabine for non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade [Phase 1, Phase 2]
Phase 1/2 trial evaluating interleukin-2 with radiotherapy and pembrolizumab in patients refractory to checkpoint blockade; results have bee…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. [Phase 1, Phase 2]
Phase 1/2a trial evaluating WEF-001 as monotherapy for safety, tolerability, pharmacokinetics, and preliminary efficacy in advanced KRAS-mut…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib
This study is recruiting to evaluate Iruplinalkib in ALK-positive advanced non-small cell lung cancer after progression on Lorlatinib, incor…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating TGI-5 as a monotherapy and in combination with nivolumab in locally advanced or metastatic solid tumors; recruiting…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients
A clinical trial update indicates that a study evaluating pembrolizumab drug concentration monitoring in patients with non-small cell lung c…